Percutaneous Cardiac Recirculation-Mediated Gene Transfer of an Inhibitory Phospholamban Peptide Reverses Advanced Heart Failure in Large Animals-Reference-Cited by-同舟云学术

Percutaneous Cardiac Recirculation-Mediated Gene Transfer of an Inhibitory Phospholamban Peptide Reverses Advanced Heart Failure in Large Animals

Published:2007-07 Issue:3 Volume:50 Page:253-260
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Kaye David M.,Preovolos Arthur,Marshall Tanneale,Byrne Melissa,Hoshijima Masahiko,Hajjar Roger,Mariani Justin A.,Pepe Salvatore,Chien Kenneth R.,Power John M.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference46 articles.

1. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult

2. Genetic maneuvers to ameliorate ventricular function in heart failure: therapeutic potential and future implications;Bukhari;Expert Rev Cardiovasc Ther,2005

3. Gene therapy in congestive heart failure;Sesti;Circulation,2004

4. Gene therapy targeted at calcium handling as an approach to the treatment of heart failure;Hoshijima;Pharmacol Ther,2005

5. Phospholamban: a crucial regulator of cardiac contractility;MacLennan;Nat Rev Mol Cell Biol,2003

Cited by 125 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pathological mutations in the phospholamban cytoplasmic region affect its topology and dynamics modulating the extent of SERCA inhibition;Biochimica et Biophysica Acta (BBA) - Biomembranes;2024-10

2. Cardiac vein retroinjections provide an efficient approach for global left ventricular gene transfer with adenovirus and adeno-associated virus;Scientific Reports;2024-01-17

3. Gene therapy for heart failure: A novel treatment for the age old disease;Disease-a-Month;2023-09

4. Phospholamban pentamerization increases sensitivity and dynamic range of cardiac relaxation;Cardiovascular Research;2023-03-03

5. Small non-coding RNA therapeutics for cardiovascular disease;European Heart Journal;2022-09-15